MAPT and Alzheimer disease: However, alteration of the catalytic activity and regulators of PP2 A and reduction of PP2 A are implicated in the pathogenesis of AD by increasing of amyloidogenesis and tau protein hyperphosphorylation and impairment of synaptic plasticity (Sontag and Sontag 2014).